Dry Eye Dx and Tx: Tech’s Role in Modern Dry Eye Diagnostics

Discover how technological advancements are refining dry eye disease evaluations and improving patient outcomes.

By
TIFFANY ANDRZEJEWSKI, OD
September 1, 2025
5 min

Contact Lens Spectrum

Objective:

To explore how technological advancements are improving the diagnosis and management of dry eye disease (DED).

Key Findings:

NIBUT is superior to fluorescein TBUT for DED diagnosis.
Tear osmolarity is a critical marker for tear film instability.
MMP-9 testing is useful but may miss mild to moderate DED.
Interferometry and meibography provide essential insights into tear film and meibomian gland health.
AI and wearable technologies promise to enhance diagnostic accuracy and patient care.

Interpretation:

Technological innovations are transforming DED diagnosis from subjective assessments to objective, data-driven evaluations, leading to improved patient outcomes.

Limitations:

Some tests may have reduced sensitivity for mild DED.
AI applications are still in early development stages.

Conclusion:

The integration of advanced technologies in DED diagnostics enhances understanding and management of the disease, paving the way for personalized treatment approaches.

Dry Eye Dx and Tx: Tech’s Role in Modern Dry Eye Diagnostics

Objective:

Key Findings:

Interpretation:

Limitations:

Conclusion:

Original Source(s)

Dry Eye Dx and Tx: Tech’s Role in Modern Dry Eye Diagnostics

Related Content

Incomplete rather than complete nasolacrimal duct obstruction Is strongly associated with meibomian gland dysfunction in postmenopausal women with PANDO: a cross-sectional study

Asymptomatic Meibomian Gland Characteristics

Japan Debuts Novel Dry Eye Therapy